Health Care

Key highlights from Pfizer’s (PFE) Q1 2025 earnings results

Key highlights from Pfizer’s (PFE) Q1 2025 earnings resultsKey highlights from Pfizer’s (PFE) Q1 2025 earnings results

Pfizer Inc. (NYSE: PFE) reported its first quarter 2025 earnings results today. Revenues decreased 8% year-over-year to $13.7 billion. GAAP…

Earnings Summary: Revvity (RVTY) reports higher revenue and earnings for Q1 2025

Earnings Summary: Revvity (RVTY) reports higher revenue and earnings for Q1 2025Earnings Summary: Revvity (RVTY) reports higher revenue and earnings for Q1 2025

Revvity, Inc. (NYSE: RVTY), a provider of health science solutions and technologies, on Monday reported an increase in revenue and…

Earnings Summary: HCA Healthcare reports higher Q1 2025 revenue and profit

Earnings Summary: HCA Healthcare reports higher Q1 2025 revenue and profitEarnings Summary: HCA Healthcare reports higher Q1 2025 revenue and profit

HCA Healthcare, Inc. (NYSE: HCA) on Friday reported an increase in revenues and net income for the first quarter of…

AbbVie Q1 2025 adjusted earnings increase on 8% revenue growth; beat estimates

AbbVie Q1 2025 adjusted earnings increase on 8% revenue growth; beat estimatesAbbVie Q1 2025 adjusted earnings increase on 8% revenue growth; beat estimates

Biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) announced first-quarter 2025 financial results, reporting an increase in revenue and adjusted earnings. The…

Bristol-Myers Squibb swings to profit in Q1 2025; revenue drops

Bristol-Myers Squibb swings to profit in Q1 2025; revenue dropsBristol-Myers Squibb swings to profit in Q1 2025; revenue drops

Bristol Myers Squibb (NYSE: BMY) reported net profit for the first quarter of 2025, compared to a loss last year.…

MRK Earnings: Merck & Co. Q1 adj. profit rises, beats estimates

MRK Earnings: Merck & Co. Q1 adj. profit rises, beats estimatesMRK Earnings: Merck & Co. Q1 adj. profit rises, beats estimates

Merck & Co. Inc. (NYSE: MRK) Thursday reported an increase in adjusted earnings for the first quarter of 2025, while…

Earnings: Intuitive Surgical (ISRG) reports higher revenue and profit for Q1 2025

Earnings: Intuitive Surgical (ISRG) reports higher revenue and profit for Q1 2025Earnings: Intuitive Surgical (ISRG) reports higher revenue and profit for Q1 2025

Healthcare technology company Intuitive Surgical Inc. (NASDAQ: ISRG) Wednesday reported a sharp increase in revenue and adjusted earnings for the…

Earnings: Highlights of Thermo Fisher Scientific’s (TMO) Q1 2025 report

Earnings: Highlights of Thermo Fisher Scientific’s (TMO) Q1 2025 reportEarnings: Highlights of Thermo Fisher Scientific’s (TMO) Q1 2025 report

Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday announced financial results for the first quarter of 2025, reporting a modest…

Infographic: How UnitedHealth Group (UNH) performed in Q1 2025

Infographic: How UnitedHealth Group (UNH) performed in Q1 2025Infographic: How UnitedHealth Group (UNH) performed in Q1 2025

UnitedHealth Group (NYSE: UNH) reported its first quarter 2025 earnings results today. Total revenues were $109.6 billion compared to $99.8…

Abbott Laboratories (ABT) Q1 2025 Earnings: Key financials and quarterly highlights

Abbott Laboratories (ABT) Q1 2025 Earnings: Key financials and quarterly highlightsAbbott Laboratories (ABT) Q1 2025 Earnings: Key financials and quarterly highlights

Abbott Laboratories (NYSE: ABT) reported its first quarter 2025 earnings results today. Total sales increased 4% year-over-year to $10.35 billion.…

JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q1 2025 financial results

Johnson & Johnson (NYSE: JNJ) reported its first quarter 2025 earnings results today. Reported sales increased 2.4% year-over-year to $21.9…

UNH Earnings Preview: Will UnitedHealth’s Q1 earnings beat expectations?

Like many insurance companies, UnitedHealth Group (NYSE: UNH) generally demonstrates the ability to remain relatively resilient during economic downturns, mainly…

Deals and R&D in focus as Johnson & Johnson gears up for Q1 earnings

For Johnson & Johnson (NYSE: JNJ), investments in its pipeline and exiting lower priority businesses remain central to its strategy…

Walgreens Boots Alliance (WBA) Q2 2025 Earnings: Key financials and quarterly highlights

Walgreens Boots Alliance (NASDAQ: WBA) reported its second quarter 2025 earnings results today. Sales increased 4.1% year-over-year to $38.6 billion.…

AngioDynamics (ANGO) Q3 2025 loss narrows; sales down 4%

Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) Wednesday reported a narrower net loss for the third quarter of 2025. Revenues…

Walgreens Boots Alliance set to report Q2 earnings. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a market leader in health and wellness services, is preparing to report second-quarter results,…

OS Therapies is actively advancing its osteosarcoma immunotherapy: CEO Paul Romness

OS Therapies (NYSE: OSTX) is a cancer immunotherapy company engaged in the development of new treatments for osteosarcoma and other…

Earnings Summary: Quest Diagnostics (DGX) reaffirms FY25 guidance

Quest Diagnostics Incorporated (NYSE: DGX), a provider of diagnostic information services, has reaffirmed its outlook for fiscal 2025 and provided…

Illumina (ILMN) expects adjusted EPS of approximately $4.50 for FY25

Biotechnology company Illumina, Inc. (NASDAQ: ILMN) has issued fresh earnings guidance for fiscal 2025, to reflect tariff-related challenges to export.…

Earnings Summary: Highlights of CooperCompanies (COO) Q1 2025 results

Medical device maker CooperCompanies (NYSE: COO) has announced financial results for the first quarter of 2025, reporting an increase in…

Earnings Summary: Highlights of Baxter International’s Q4 2024 report

Baxter International Inc. (NYSE: BAX) on Thursday announced financial results for the fourth quarter of 2024. The medical device maker's…